1-20 of 758
Section: Original Papers
Sort by
Journal Article
Feasibility and Efficacy of Microwave Ablation Combined with Iodine‐125 Seed Implantation in Local Control of Recurrent Retroperitoneal Liposarcomas: Initial Clinical Experience
Mingjian Lu and others
The Oncologist, Volume 22, Issue 12, December 2017, Pages 1500–1505, https://doi.org/10.1634/theoncologist.2016-0499
Published: 04 December 2017
Journal Article
2017 Chabner Colloquium Answering the Big Questions in Cancer Research Annual Meeting Abstracts
The Oncologist, Volume 22, Issue s1, October 2017, Pages S1–S4, https://doi.org/10.1634/theoncologist.2017-MA-1
Published: 27 October 2017
Journal Article
Regarding “Survival Outcomes in Asymptomatic Patients with Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography‐Computed Tomography Imaging”
Fergus Macbeth and Tom Treasure
The Oncologist, Volume 22, Issue 11, November 2017, Page 1411, https://doi.org/10.1634/theoncologist.2017-0051
Published: 10 August 2017
Journal Article
Volume 21 Acknowledgments
The Oncologist, Volume 21, Issue 12, December 2016, Pages 1551–1553, https://doi.org/10.1634/theoncologist.2016-r000
Published: 06 December 2016
Journal Article
Volume 21 Author Index
The Oncologist, Volume 21, Issue 12, December 2016, Pages 1542–1550, https://doi.org/10.1634/theoncologist.2016-a000
Published: 06 December 2016
Journal Article
Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum-Based Therapy
Jean-Pascal Henry Machiels and others
The Oncologist, Volume 21, Issue 12, December 2016, Pages 1416–e17, https://doi.org/10.1634/theoncologist.2016-0296
Published: 30 November 2016
Journal Article
Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance)
Preet Paul Singh and others
The Oncologist, Volume 21, Issue 12, December 2016, Pages 1509–1521, https://doi.org/10.1634/theoncologist.2016-0153
Published: 23 November 2016
Journal Article
A Case of Nivolumab-Induced Myositis
Eric Fox and others
The Oncologist, Volume 21, Issue 12, December 2016, Page e3, https://doi.org/10.1634/theoncologist.2016-0170
Published: 18 November 2016
Journal Article
Tumor Humor?
Benjamin W. Corn
The Oncologist, Volume 21, Issue 12, December 2016, Pages 1538–1539, https://doi.org/10.1634/theoncologist.2016-0413
Published: 18 November 2016
Journal Article
The Elimination of Cancer Health Disparities: Are We Ready to Do the Heavy Lifting?
Jonathan D. Jackson and others
The Oncologist, Volume 21, Issue 12, December 2016, Pages 1411–1413, https://doi.org/10.1634/theoncologist.2016-0327
Published: 07 November 2016
Journal Article
In Memoriam: A Tribute to Daniel J. Sargent, Ph.D.
Richard M. Goldberg
The Oncologist, Volume 21, Issue 12, December 2016, Pages 1540–1541, https://doi.org/10.1634/theoncologist.2016-0425
Published: 07 November 2016
Journal Article
hENT-1 Expression and Localization Predict Outcome After Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients
Laura L. Meijer and others
The Oncologist, Volume 21, Issue 12, December 2016, Page e4, https://doi.org/10.1634/theoncologist.2016-0262
Published: 02 November 2016
Journal Article
Bridging the Gap Between Sorafinib Efficacy and Effectiveness in Advanced Hepatocellular Carcinoma
Ryan Nipp and Lipika Goyal
The Oncologist, Volume 21, Issue 11, November 2016, Pages 1283–1285, https://doi.org/10.1634/theoncologist.2016-0349
Published: 02 November 2016
Journal Article
Targeting the KRAS Pathway in Non-Small Cell Lung Cancer
Pascale Tomasini and others
The Oncologist, Volume 21, Issue 12, December 2016, Pages 1450–1460, https://doi.org/10.1634/theoncologist.2015-0084
Published: 02 November 2016
Journal Article
In Reply
Giovanni Brandi and others
The Oncologist, Volume 21, Issue 12, December 2016, Pages e5–e6, https://doi.org/10.1634/theoncologist.2016-0286
Published: 02 November 2016
Journal Article
A Phase I Study of the Safety and Pharmacokinetics of Higher-Dose Icotinib in Patients With Advanced Non-Small Cell Lung Cancer
Jian Liu and others
The Oncologist, Volume 21, Issue 11, November 2016, Pages 1294–1295d, https://doi.org/10.1634/theoncologist.2016-0256
Published: 27 October 2016
Journal Article
A Phase I/II Study of the Investigational Drug Alisertib in Combination With Abiraterone and Prednisone for Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Abiraterone
Jianqing Lin and others
The Oncologist, Volume 21, Issue 11, November 2016, Pages 1296–1297e, https://doi.org/10.1634/theoncologist.2016-0297
Published: 24 October 2016
Journal Article
Eribulin in Male Patients With Breast Cancer: The First Report of Clinical Outcomes
Francesco Giotta and others
The Oncologist, Volume 21, Issue 11, November 2016, Pages 1298–1305, https://doi.org/10.1634/theoncologist.2016-0022
Published: 14 October 2016
Journal Article
Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging
Khurum Khan and others
The Oncologist, Volume 21, Issue 12, December 2016, Pages 1502–1508, https://doi.org/10.1634/theoncologist.2016-0222
Published: 14 October 2016
Journal Article
Phase II Trial of Abiraterone Acetate Plus Prednisone in Black Men With Metastatic Prostate Cancer
Che-Kai Tsao and others
The Oncologist, Volume 21, Issue 12, December 2016, Pages 1414–e9, https://doi.org/10.1634/theoncologist.2016-0026
Published: 14 October 2016
Advertisement
Advertisement